A comprehensive analysis of HIV/AIDS funding by the Lancet has revealed that more than half a trillion dollars have been spent on the disease worldwide between 2000 and 2015.
The study showed that the total health spending, separated by the source into government spending, out-of-pocket, prepaid private and development assistance for health was $562.6 billion during the 16-year period.
Study: Key Highlights
• The study reported that while the annual spending of health peaked in 2013 with $49.7 billion, $48.9 billion was provided in 2015 for the care, treatment and prevention of the disease.
• The largest source of funds for the treatment and care of the disease in 2015 were the governments, who contributed around 29.8 billion or 61 per cent of the total spending on HIV/AIDS.
• In comparison, prepaid spending from the private sector turned out to be the smallest, making up only $1.4 billion of the 2015 total.
• Besides, the Development assistance for health (DAH), which includes the funding from high-income nations to support health efforts in lower-income ones, made up 0.5 per cent of the total health spending globally in 2015.
• The DAH totaled 30 per cent of all HIV/AIDS spending in 2015.
Video: Check out the latest current affairs of this week
• The research is significant, as it is an important step towards global disease-specific resource tracking, which makes new and policy-relevant analyses possible, including understanding the drivers of health spending growth.
• Through the survey, the researchers are quantifying spending gaps and evaluating the impact of expenditures.
Overall, the survey was conducted by Lancet team in coordination with a group of 256 researchers in 63 countries.
About the Lancet
• The Lancet is one of the world's oldest and best known general medical journals.
• It was founded in 1823 by Thomas Wakley, an English surgeon who named it after the surgical instrument called a lancet.
• The journal publishes original research articles, review articles, seminars and reviews, editorials, book reviews, correspondence, as well as news features and case reports.
• The journal is owned by Elsevier since 1991. Elsevier is a Dutch information and analytics company and one of the world's major providers of scientific, technical, and medical information.
• The journal has editorial offices in London, New York, and Beijing.
Who: Lancet report
DISCLAIMER: JPL and its affiliates shall have no liability for any views, thoughts and comments expressed on this article.